Tusk Therapeutics' Acquisition

Tusk Therapeutics was acquired by Roche Holding on September 28, 2018.

Tusk Therapeutics is an immuno-oncology company, focused on discovering and developing therapeutic antibodies for the treatment of cancer.…

Articles about Tusk Therapeutics' Acquisition: